[{"address1": "10955 Vista Sorrento Parkway", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 751 4493", "website": "https://www.januxrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. David Alan Campbell Ph.D.", "age": 64, "title": "President, CEO & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 1037500, "exercisedValue": 0, "unexercisedValue": 9922011}, {"maxAge": 1, "name": "Mr. Charles M. Winter", "age": 55, "title": "Chief Technical Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 590400, "exercisedValue": 0, "unexercisedValue": 460878}, {"maxAge": 1, "name": "Mr. Byron  Robinson J.D., Ph.D.", "age": 59, "title": "Chief Strategy Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 723000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Whitmire", "title": "Vice President of Finance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tommy  Diraimondo Ph.D.", "age": 38, "title": "Chief Scientific Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Pennington", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andy Hollman Meyer", "age": 40, "title": "Chief Business Officer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Zachariah  McIver D.O., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 32.01, "open": 32.37, "dayLow": 31.955, "dayHigh": 33.3, "regularMarketPreviousClose": 32.01, "regularMarketOpen": 32.37, "regularMarketDayLow": 31.955, "regularMarketDayHigh": 33.3, "payoutRatio": 0.0, "forwardPE": -20.55625, "volume": 966747, "regularMarketVolume": 966747, "averageVolume": 1231359, "averageVolume10days": 822210, "averageDailyVolume10Day": 822210, "bid": 32.76, "ask": 33.04, "bidSize": 1, "askSize": 1, "marketCap": 1943966720, "fiftyTwoWeekLow": 31.69, "fiftyTwoWeekHigh": 71.71, "priceToSalesTrailing12Months": 183.60094, "fiftyDayAverage": 45.3536, "twoHundredDayAverage": 46.454327, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 941820288, "profitMargins": 0.0, "floatShares": 37586145, "sharesOutstanding": 59105100, "sharesShort": 9091177, "sharesShortPriorMonth": 8552992, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.1551, "heldPercentInsiders": 0.07048, "heldPercentInstitutions": 1.13639, "shortRatio": 9.48, "shortPercentOfFloat": 0.2767, "impliedSharesOutstanding": 58632800, "bookValue": 17.316, "priceToBook": 1.8993994, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -68994000, "trailingEps": -1.28, "forwardEps": -1.6, "enterpriseToRevenue": 88.952, "enterpriseToEbitda": -9.731, "52WeekChange": -0.24876791, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 32.89, "targetHighPrice": 200.0, "targetLowPrice": 25.0, "targetMeanPrice": 89.15385, "targetMedianPrice": 81.0, "recommendationMean": 1.21429, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 13, "totalCash": 1025172992, "totalCashPerShare": 17.345, "ebitda": -96787000, "totalDebt": 23025000, "quickRatio": 58.719, "currentRatio": 59.205, "totalRevenue": 10588000, "debtToEquity": 2.251, "revenuePerShare": 0.197, "returnOnAssets": -0.08569, "returnOnEquity": -0.100930005, "grossProfits": 10588000, "freeCashflow": -59164376, "operatingCashflow": -43814000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -9.33576, "financialCurrency": "USD", "symbol": "JANX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Janux Therapeutics, Inc.", "shortName": "Janux Therapeutics, Inc.", "gmtOffSetMilliseconds": -18000000, "esgPopulated": false, "regularMarketChangePercent": 2.7491443, "regularMarketPrice": 32.89, "fiftyDayAverageChange": -12.4636, "fiftyDayAverageChangePercent": -0.2748095, "twoHundredDayAverageChange": -13.564327, "twoHundredDayAverageChangePercent": -0.29199275, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-11", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1740789893, "regularMarketTime": 1740776401, "exchange": "NGM", "messageBoardId": "finmb_676965261", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "market": "us_market", "marketState": "CLOSED", "postMarketChangePercent": 0.39526, "postMarketPrice": 33.02, "postMarketChange": 0.130001, "regularMarketChange": 0.88000107, "regularMarketDayRange": "31.955 - 33.3", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1231359, "fiftyTwoWeekLowChange": 1.1999989, "fiftyTwoWeekLowChangePercent": 0.037866797, "fiftyTwoWeekRange": "31.69 - 71.71", "fiftyTwoWeekHighChange": -38.82, "fiftyTwoWeekHighChangePercent": -0.5413471, "fiftyTwoWeekChangePercent": -24.876791, "earningsTimestampStart": 1746475200, "earningsTimestampEnd": 1746907200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.28, "epsForward": -1.6, "epsCurrentYear": -2.11333, "priceEpsCurrentYear": -15.563117, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623418200000, "displayName": "Janux Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]